SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 402.70 |
| Enterprise Value ($M) | 349.47 |
| Book Value ($M) | 421.54 |
| Book Value / Share | 6.87 |
| Price / Book | 0.96 |
| NCAV ($M) | 367.77 |
| NCAV / Share | 5.99 |
| Price / NCAV | 1.09 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.32 |
| Return on Equity (ROE) | -0.38 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 12.40 |
| Current Ratio | 12.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 479.16 |
| Assets | 532.93 |
| Liabilities | 111.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | State Street Corp | 10.57 | 26.90 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 10.70 | 11.84 | |
| 13G/A | Forbion Capital Fund III Cooperatief U.A. | 8.70 | 1.50 | |
| 13G/A | Redmile Group, LLC | 7.40 | -19.78 | |
| 13G/A | Omega Fund IV, L.P. | 5.50 | -9.98 | |
| 13G | Morgan Stanley | 7.40 | ||
| 13G/A | BlackRock Inc. | 7.70 | 50.75 | |
| 13G/A | Baker Bros. Advisors Lp | 16.20 | 65.48 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 57,331 | 419,537 | 13.67 | |
| 55,121 | 237,086 | 23.25 | |
| 67,765 | 522,708 | 12.96 | |
| 58,300 | 226,753 | 25.71 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RARE – Ultragenyx Pharmaceutical Inc. | RDUS – Radius Recycling, Inc. |
| REGN – Regeneron Pharmaceuticals, Inc. | RGEN – Repligen Corporation |
| RGNX – REGENXBIO Inc. |
Financial data and stock pages provided by
Fintel.io